Seth Eisenman is a scientist by training and has worked for more than a decade in wet labs at Mayo Clinic, before joining the ventures team at the US-based non-profit healthcare company. The experience has given him a strong insight into innovation and technology development.
Mayo Clinic Ventures is the unit tasked with commercialising innovations developed at Mayo Clinic, as well as collaborating with and investing in external startups developing cutting-edge solutions.
“It is contingent that we have some collaborative relationship with the companies we invest in, whether that is advancing a Mayo Clinic technology, or providing research and clinical expertise,” says Eisenman.
Because Mayo Clinic specialises in treating some of the most serious and complex medical conditions, the organisation is in a unique position to help startups working in these areas.
If our industry collaborators are innovating in markets that need that expertise, we can provide the clinical knowledge on our side.
“We often have the top experts in the world in certain indications. If our industry collaborators are innovating in markets that need that expertise, we can provide the clinical knowledge on our side,” he says.
The Mayo Clinic Ventures team includes more than 90 people and is growing fast, doubling over the past three years.
Eisenman is valued by his team as a strong leader and mentor and for helping foster an innovation ecosystem across the organisation.
One of the most exciting things for Eisenman is the opportunity to use generative artifi cial
intelligence to decrease routine tasks of healthcare providers. The technology has the potential to automate the analysis of diagnostic images and samples, and quickly find critical information in patients’ medical records.
Mayo Clinic unveiled a new strategic collaboration with AI startup Cerebras Systems to develop multimodal large language models to improve patient outcomes and diagnoses.
See the full list of GCV Rising Stars for 2024 here.